Bernard W. Downs*, Steve Kushner, Manashi Bagchi, Kenneth Blum, Rajendra D. Badgaiyan, Sanjoy Chakraborty and Debasis Bagchi Pages 123 - 137 ( 15 )
Background: Conventional medical therapies for neurodegenerative diseases primarily target anti-inflammatory interventions, immune suppression of autoimmune pathologies, and, depending on the diagnosed pathological mechanisms, neurotransmitter reuptake inhibition, among other tactics. However, the incidence of neuroinflammatory pathologies appears to be progressively increasing. The National Institutes of Health, National Institute of Environmental Health Sciences in 2016, estimated that 5.4 million Americans were living with Alzheimer's. If no effective solutions are found and implemented, within 30 years of this publication, according to data from Harvard, more than 12 million Americans will suffer from neurodegenerative diseases.
Methods: Rather than investigating greater etiological depth, modern medicine seems to have been designed to addressing obvious symptomologies to relieve suffering for as long as possible until neuropathological progress inevitably wins in achieving complete functional disability and death. Researchers are reporting herein evidence-based effective treatment therapies that are outside conventional medical standard of care therapies.
Conclusion: These therapies are the result of a deeper exploration into etiological factors, including an expanded understanding of the role of anaerobic pathologies in the etiology of neuroinflammatory disorders and methods of reverting to a competent aerobic metabolism. Such therapies include a liquid VMP35 MNC; a greater focus on viral mechanistic pathologies and their remission; and understanding of the genetic basis for a loss of neurological interconnectivity and consequential reward deficiencies in combination with neuronutrient deficiencies, enabling neuronutrient repletion with nutrigenomic therapies such as the KB220Z.
Neuroinflammation, neurodegeneration, oxidative stress, cytokines, aerobic pathology, autophagy, Herpes virus, phytonutrients.
VNI Inc., Lederach, PA, ALM R&D, Oldsmar, FL, Dr. Herbs LLC, Concord, CA, Graduate College, Western University Health Science, Pomona, CA, Department of Psychiatry, Long School of Medicine, University of Texas Health Science Center, San Antonio, Texas TX, Department of Biological Sciences, New York City College of Technology/CUNY, Brooklyn, NY, College of Pharmacy and Health Sciences, Texas Southern University, Houston, TX 77002